Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KALINSKY K, Lee S, Rubin KM, Lawrence DP, et al
    A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30663.
    PubMed     Text format     Abstract available


    February 2017

  2. Some Europeans with melanoma lack access to new, lifesaving drugs.
    Cancer. 2017;123:543-544.
    PubMed     Text format    


  3. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available


    December 2016
  4. HOU JY, Baptiste C, Hombalegowda RB, Tergas AI, et al
    Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30473.
    PubMed     Text format     Abstract available


  5. KIM DW, Haydu LE, Joon AY, Bassett RL Jr, et al
    Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
    Cancer. 2016 Dec 2. doi: 10.1002/cncr.30463.
    PubMed     Text format     Abstract available


  6. YILMAZ AS, Ozer HG, Gillespie JL, Allain DC, et al
    Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30459.
    PubMed     Text format     Abstract available


    October 2016
  7. CLARKE LE, Flake DD 2nd, Busam K, Cockerell C, et al
    An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.
    Cancer. 2016 Oct 21. doi: 10.1002/cncr.30385.
    PubMed     Text format     Abstract available


    August 2016
  8. BHATIA S, Margolin K
    Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30260.
    PubMed     Text format    


  9. SHOUSHTARI AN, Munhoz RR, Kuk D, Ott PA, et al
    The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30259.
    PubMed     Text format     Abstract available


  10. ALGAZI AP, Tsai KK, Shoushtari AN, Munhoz RR, et al
    Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-1L antibodies.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30258.
    PubMed     Text format     Abstract available


  11. JHAWAR SR, Kaufman HL, Goyal S
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30244.
    PubMed     Text format    


  12. YU JB, Chiang VL
    Reply to timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30243.
    PubMed     Text format    


    July 2016
  13. CURIEL-LEWANDROWSKI C, Swetter SM
    Lack of harms from community-based melanoma screening by primary care providers.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30194.
    PubMed     Text format    


  14. WEINSTOCK MA, Ferris LK, Saul MI, Geller AC, et al
    Downstream consequences of melanoma screening in a community practice setting: First results.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30177.
    PubMed     Text format     Abstract available


    June 2016
  15. BJURSTAM NG, Bjorneld LM, Duffy SW
    Updated results of the Gothenburg Trial of Mammographic Screening.
    Cancer. 2016;122:1832-5.
    PubMed     Text format     Abstract available


  16. GUINDALINI RS, Song A, Fackenthal JD, Olopade OI, et al
    Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.
    Cancer. 2016;122:1913-20.
    PubMed     Text format     Abstract available


  17. QIAN JM, Yu JB, Kluger HM, Chiang VL, et al
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30138.
    PubMed     Text format     Abstract available


    May 2016
  18. VERMA V, Mishra MV, Mehta MP
    A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Cancer. 2016;122:1483-501.
    PubMed     Text format     Abstract available


  19. FERGUSON RJ, Sigmon ST, Pritchard AJ, LaBrie SL, et al
    A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Cancer. 2016 May 2. doi: 10.1002/cncr.29891.
    PubMed     Text format     Abstract available


  20. PRINTZ C
    Delaying chemotherapy after surgery in patients with breast cancer reduces survival.
    Cancer. 2016;122:1311.
    PubMed     Text format    


    April 2016
  21. PRINTZ C
    FDA approves new treatment of metastatic melanoma.
    Cancer. 2016;122:1149.
    PubMed     Text format    


  22. PRINTZ C
    BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
    Cancer. 2016;122:1149.
    PubMed     Text format    


  23. DRILON A, Eaton AA, Schindler K, Gounder MM, et al
    Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program.
    Cancer. 2016;122:1228-37.
    PubMed     Text format     Abstract available


  24. SHAH PD, Patil S, Dickler MN, Offit K, et al
    Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
    Cancer. 2016;122:1178-84.
    PubMed     Text format     Abstract available


  25. PRINTZ C
    Minority women more likely to develop aggressive breast cancer.
    Cancer. 2016;122:986-7.
    PubMed     Text format    


    March 2016
  26. CHATTOPADHYAY C, Kim DW, Gombos DS, Oba J, et al
    Uveal melanoma: From diagnosis to treatment and the science in between.
    Cancer. 2016 Mar 15. doi: 10.1002/cncr.29727.
    PubMed     Text format     Abstract available


  27. PRINTZ C
    ACS updates breast cancer screening guidelines.
    Cancer. 2016;122:663.
    PubMed     Text format    


  28. PRINTZ C
    Developments in precision medicine: Studies highlight new applications for cancer chemoprevention, treatment.
    Cancer. 2016;122:661-2.
    PubMed     Text format    


  29. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available


    February 2016
  30. ARMSTRONG K, Kim JJ, Halm EA, Ballard RM, et al
    Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Cancer. 2016 Feb 29. doi: 10.1002/cncr.29937.
    PubMed     Text format     Abstract available


  31. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  32. HAAS JS, Hill DA, Wellman RD, Hubbard RA, et al
    Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.
    Cancer. 2016;122:611-7.
    PubMed     Text format     Abstract available


  33. LIGIBEL JA, Giobbie-Hurder A, Shockro L, Campbell N, et al
    Randomized trial of a physical activity intervention in women with metastatic breast cancer.
    Cancer. 2016 Feb 12. doi: 10.1002/cncr.29899.
    PubMed     Text format     Abstract available


  34. TRICOLI JV, Blair DG, Anders CK, Bleyer A, et al
    Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.
    Cancer. 2016 Feb 5. doi: 10.1002/cncr.29871.
    PubMed     Text format     Abstract available



  35. Breast cancer incidence and death increasing in less-developed countries.
    Cancer. 2016;122:339.
    PubMed     Text format    



  36. Prenatal exposure to maternal cancer with or without treatment does not impair child development.
    Cancer. 2016;122:338-9.
    PubMed     Text format    



  37. Women at low risk for breast cancer recurrence can avoid chemotherapy: Initial trial findings support current practices.
    Cancer. 2016;122:337-338.
    PubMed     Text format    


  38. TEVAARWERK AJ, Lee JW, Terhaar A, Sesto ME, et al
    Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
    Cancer. 2016;122:438-46.
    PubMed     Text format     Abstract available


  39. STOVER AM, Basch EM
    Using patient-reported outcome measures as quality indicators in routine cancer care.
    Cancer. 2016;122:355-7.
    PubMed     Text format    


  40. SMITH TG, Castro KM, Troeschel AN, Arora NK, et al
    The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.
    Cancer. 2016;122:344-51.
    PubMed     Text format     Abstract available


  41. KAYMAKCALAN MD, Xie W, Albiges L, North SA, et al
    Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Ca
    Cancer. 2016;122:411-9.
    PubMed     Text format     Abstract available


  42. VISSCHER DW, Frost MH, Hartmann LC, Frank RD, et al
    Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
    Cancer. 2016;122:378-85.
    PubMed     Text format     Abstract available


    January 2016
  43. LAI JS, Beaumont JL, Diaz J, Khan S, et al
    Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinoma.
    Cancer. 2016;122:287-95.
    PubMed     Text format     Abstract available


  44. BLEICHER RJ, Ruth K, Sigurdson ER, Daly JM, et al
    Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.
    Cancer. 2016;122:42-9.
    PubMed     Text format     Abstract available


    December 2015
  45. KUMACHEV A, Trudeau ME, Chan KK
    Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29838.
    PubMed     Text format     Abstract available


  46. HAHN EE, Tang T, Lee JS, Munoz-Plaza CE, et al
    Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29811.
    PubMed     Text format     Abstract available


  47. CHURPEK JE, Marquez R, Neistadt B, Claussen K, et al
    Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
    Cancer. 2015 Dec 7. doi: 10.1002/cncr.29615.
    PubMed     Text format     Abstract available


  48. PRINTZ C
    Younger patients with breast cancer may decline tamoxifen due to fertility concerns.
    Cancer. 2015;121:4103.
    PubMed     Text format    


    November 2015
  49. BURNSIDE ES, Drukker K, Li H, Bonaccio E, et al
    Using computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage.
    Cancer. 2015 Nov 30. doi: 10.1002/cncr.29791.
    PubMed     Text format     Abstract available


  50. LEBO PB, Quehenberger F, Kamolz LP, Lumenta DB, et al
    The Angelina effect revisited: Exploring a media-related impact on public awareness.
    Cancer. 2015;121:3959-64.
    PubMed     Text format     Abstract available


  51. RAMACHANDRAN A, Snyder FR, Katz ML, Darnell JS, et al
    Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Cancer. 2015;121:4016-24.
    PubMed     Text format     Abstract available


  52. GARCIA MK, Graham-Getty L, Haddad R, Li Y, et al
    Systematic review of acupuncture to control hot flashes in cancer patients.
    Cancer. 2015;121:3948-58.
    PubMed     Text format     Abstract available


  53. COLLINS LC, Aroner SA, Connolly JL, Colditz GA, et al
    Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.
    Cancer. 2015 Nov 13. doi: 10.1002/cncr.29775.
    PubMed     Text format     Abstract available


  54. NYROP KA, Deal AM, Williams GR, Guerard EJ, et al
    Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer.
    Cancer. 2015 Nov 13. doi: 10.1002/cncr.29786.
    PubMed     Text format     Abstract available


  55. HASSETT MJ, Schymura MJ, Chen K, Boscoe FP, et al
    Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.
    Cancer. 2015 Nov 4. doi: 10.1002/cncr.29777.
    PubMed     Text format     Abstract available


  56. PRINTZ C
    Removing more breast tissue in mastectomy can reduce need for second surgery.
    Cancer. 2015;121:3753.
    PubMed     Text format    


  57. TRAEGER L, McDonnell TM, McCarty CE, Greer JA, et al
    Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Cancer. 2015;121:3905-13.
    PubMed     Text format     Abstract available


    October 2015
  58. DAWES AJ, Maggard-Gibbons M
    Reply to The long and winding road in cancer survivorship care.
    Cancer. 2015;121:3750.
    PubMed     Text format    


  59. ZANET E, Michieli M, Tirelli U
    The long and winding road in cancer survivorship care.
    Cancer. 2015;121:3748-9.
    PubMed     Text format    


  60. PRINTZ C
    Diastolic dysfunction common among breast cancer patients receiving anthracycline.
    Cancer. 2015;121:3563.
    PubMed     Text format    


  61. FROES BRANDAO D, Strasser-Weippl K, Goss PE
    Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
    Cancer. 2015 Oct 12. doi: 10.1002/cncr.29714.
    PubMed     Text format     Abstract available


  62. SANFORD RA, Song J, Gutierrez-Barrera AM, Profato J, et al
    High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
    Cancer. 2015;121:3422-7.
    PubMed     Text format     Abstract available


    September 2015
  63. HAN D, Iyer JG
    Prognostic factors and immunobiologic insights into Merkel cell carcinoma.
    Cancer. 2015;121:3193-6.
    PubMed     Text format    


  64. SMITH FO, Yue B, Marzban SS, Walls BL, et al
    Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma.
    Cancer. 2015;121:3252-60.
    PubMed     Text format     Abstract available


  65. BISHOP AJ, Ensor J, Moulder SL, Shaitelman SF, et al
    Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
    Cancer. 2015 Sep 8. doi: 10.1002/cncr.29681.
    PubMed     Text format     Abstract available


  66. PRINTZ C
    Sunscreen slow down: The US FDA's sluggish approval of new sunscreens frustrates physicians, manufacturers, and consumers.
    Cancer. 2015;121:2861-2.
    PubMed     Text format    


  67. EXTERMANN M, Reich RR, Sehovic M
    Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.
    Cancer. 2015;121:2984-92.
    PubMed     Text format     Abstract available


    August 2015
  68. PHILLIPS SM, Awick EA, Conroy DE, Pellegrini CA, et al
    Objectively measured physical activity and sedentary behavior and quality of life indicators in survivors of breast cancer.
    Cancer. 2015 Aug 26. doi: 10.1002/cncr.29620.
    PubMed     Text format     Abstract available


  69. POTOSKY AL, O'Neill SC, Isaacs C, Tsai HT, et al
    Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.
    Cancer. 2015 Aug 20. doi: 10.1002/cncr.29621.
    PubMed     Text format     Abstract available


  70. KOHLER RE, Goyal RK, Lich KH, Domino ME, et al
    Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program.
    Cancer. 2015 Aug 19. doi: 10.1002/cncr.29596.
    PubMed     Text format     Abstract available


  71. PAL T, Bonner D, Cragun D, Monteiro AN, et al
    A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
    Cancer. 2015 Aug 19. doi: 10.1002/cncr.29645.
    PubMed     Text format     Abstract available


  72. CHEN S, Ibrahim NK, Yan Y, Wong ST, et al
    Risk stratification in patients with advanced-stage breast cancer by pretreatment [ F]FDG PET/CT.
    Cancer. 2015 Aug 6. doi: 10.1002/cncr.29565.
    PubMed     Text format     Abstract available


    July 2015
  73. CRONIN-FENTON DP, Heide-Jorgensen U, Ahern TP, Lash TL, et al
    Opioids and breast cancer recurrence: A Danish population-based cohort study.
    Cancer. 2015 Jul 24. doi: 10.1002/cncr.29532.
    PubMed     Text format     Abstract available


  74. WHITE AJ, Nichols HB, Bradshaw PT, Sandler DP, et al
    Overall and central adiposity and breast cancer risk in the sister study.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29552.
    PubMed     Text format     Abstract available


    June 2015
  75. VON MINCKWITZ G, Conrad B, Reimer T, Decker T, et al
    A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
    Cancer. 2015 Jun 25. doi: 10.1002/cncr.29506.
    PubMed     Text format     Abstract available


  76. ROSELAND ME, Pressler ME, E Lamerato L, Krajenta R, et al
    Racial differences in breast cancer survival in a large urban integrated health system.
    Cancer. 2015 Jun 25. doi: 10.1002/cncr.29523.
    PubMed     Text format     Abstract available


  77. WANG J, Xu B, Yuan P, Ma F, et al
    Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial.
    Cancer. 2015 Jun 19. doi: 10.1002/cncr.29492.
    PubMed     Text format     Abstract available


  78. FEDEWA SA, Goodman M, Flanders WD, Han X, et al
    Elimination of cost-sharing and receipt of screening for colorectal and breast cancer.
    Cancer. 2015 Jun 4. doi: 10.1002/cncr.29494.
    PubMed     Text format     Abstract available


    March 2015
  79. UNGER-SALDANA K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, et al
    Health system delay and its effect on clinical stage of breast cancer: Multicenter study.
    Cancer. 2015 Mar 24. doi: 10.1002/cncr.29331.
    PubMed     Text format     Abstract available


  80. KHANKARI NK, Bradshaw PT, Steck SE, He K, et al
    Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York.
    Cancer. 2015 Mar 24. doi: 10.1002/cncr.29329.
    PubMed     Text format     Abstract available


  81. SIGHOKO D, Ogundiran T, Ademola A, Adebamowo C, et al
    Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda.
    Cancer. 2015 Mar 17. doi: 10.1002/cncr.29305.
    PubMed     Text format     Abstract available


  82. CHLEBOWSKI RT, Schottinger JE, Shi J, Chung J, et al
    Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.
    Cancer. 2015 Mar 10. doi: 10.1002/cncr.29332.
    PubMed     Text format     Abstract available


  83. CRAMER H, Rabsilber S, Lauche R, Kummel S, et al
    Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial.
    Cancer. 2015 Mar 4. doi: 10.1002/cncr.29330.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: